Unicycive Therapeutics Inc. (UNCY)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
5. 38
+0.33
+6.5347%
$
112.19M Market Cap
- P/E Ratio
- Div Yield
1.35M Volume
-0.49 Eps
$ 5.05
Previous Close 
Want to track UNCY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Unicycive Therapeutics Inc. (UNCY) Statistics
Valuation metrics
Market Cap 112.19M
Enterprise value 79.19M
Trailing P/E (ttm) -2.62
Forward P/E -
PEG ratio 0.09
Price/Sales (ttm) -
Price/Book (mrq) 34.11
Enterprise Value/Revenue -
Enterprise Value/EBITDA -2.02
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.32M
Average volume (90 days) 945.15K
Price summary
52-Week low 3.71
52-Week high 8.74
Beta -
50-Day moving average 6.92
200-Day moving average 6.88
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 20 Jun 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.62%
Return on equity -1.31%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.17
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.23
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 2.4%
Book value per share (mrq) 0.16
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
